Randomized double‐blind placebo‐controlled cosmetic trial of a topical first‐in‐class Neutraligand targeting the chemokine TARC/CCL17 in mild‐to‐moderate atopic dermatitis. - Frossard, Nelly; Coïc, Alexandra; Saguet, Thibaut; Coïc, Alain; Himbert, Franck; Do, Quoc Tuan; Galzi, Jean‐Luc; Suehs, Carey; Guillaumet, Gerald; Bonnet, Pascal; Bernard, Philippe (International Journal of Cosmetic Science, 2024)